Cooper Other Operating Income or Expenses 2010-2024 | COO

Cooper annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Cooper other operating income or expenses for the quarter ending July 31, 2024 were $M, a NAN% increase year-over-year.
  • Cooper other operating income or expenses for the twelve months ending July 31, 2024 were $0M, a NAN% increase year-over-year.
  • Cooper annual other operating income or expenses for 2023 were $0B, a NAN% decline from 2022.
  • Cooper annual other operating income or expenses for 2022 were $0B, a NAN% decline from 2021.
  • Cooper annual other operating income or expenses for 2021 were $0B, a NAN% decline from 2020.
Cooper Annual Other Operating Income or Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $19
2018 $-24
2017 $
2016 $0
2015 $
2014 $
2013 $-21
2012 $
2011 $
2010 $
2009 $
Cooper Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-07-31
2024-04-30
2024-01-31
2023-10-31
2023-07-31
2023-04-30
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31
2020-04-30
2020-01-31
2019-10-31 $-0
2019-07-31
2019-04-30 $19
2019-01-31
2018-10-31
2018-07-31
2018-04-30 $-24
2018-01-31
2017-10-31
2017-07-31
2017-04-30
2017-01-31
2016-10-31
2016-07-31
2016-04-30
2016-01-31
2015-10-31
2015-07-31
2015-04-30
2015-01-31
2014-10-31
2014-07-31
2014-04-30
2014-01-31
2013-10-31
2013-07-31
2013-04-30
2013-01-31
2012-10-31
2012-07-31
2012-04-30
2012-01-31
2011-10-31
2011-07-31
2011-04-30
2011-01-31
2010-10-31
2010-07-31 $0
2010-04-30
2010-01-31
2009-10-31
2009-07-31
2009-04-30
2009-01-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.726B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36